200 related articles for article (PubMed ID: 21738271)
1. Assessment of loiasis and outcomes of ivermectin masstreatment in Ijebu-North, Nigeria.
Hassan AA; Akinsanya B; Iyase N; Owagboriaye FO
Korean J Parasitol; 2011 Jun; 49(2):153-9. PubMed ID: 21738271
[TBL] [Abstract][Full Text] [Related]
2. In Southern Nigeria
Emukah E; Rakers LJ; Kahansim B; Miri ES; Nwoke BEB; Griswold E; Saka Y; Anagbogu I; Davies E; Ityonzughul C; D'Ambrosio M; Bakalar M; Fletcher DA; Nutman T; Kamgno J; Richards FO
Am J Trop Med Hyg; 2018 Jul; 99(1):116-123. PubMed ID: 29761763
[TBL] [Abstract][Full Text] [Related]
3. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
[TBL] [Abstract][Full Text] [Related]
4. Rapid assessment method for prevalence and intensity of Loa loa infection.
Takougang I; Meremikwu M; Wandji S; Yenshu EV; Aripko B; Lamlenn SB; Eka BL; Enyong P; Meli J; Kale O; Remme JH
Bull World Health Organ; 2002; 80(11):852-8. PubMed ID: 12481206
[TBL] [Abstract][Full Text] [Related]
5. Prevalences of loiasis in Ondo state, Nigeria, as evaluated by the rapid assessment procedure for loiasis (RAPLOA).
Adeoye GO; Akinsanya B; Otubanjo AO; Ibidapo CA; Atalabi T; Okwuzu J; Adejai EO; Braide EI
Ann Trop Med Parasitol; 2008 Apr; 102(3):215-27. PubMed ID: 18348776
[TBL] [Abstract][Full Text] [Related]
6. Market survey of loiasis: prevalence and adverse reactions to ivermectin using a rapid procedure for loiasis.
Ibidapo CA; Akinsanya B; Adeoye GO; Otubanjo AO; Okeke P; Okwuzu J; Adejai EO; Braide E
West Indian Med J; 2008 Mar; 57(2):152-6. PubMed ID: 19565959
[TBL] [Abstract][Full Text] [Related]
7. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
[TBL] [Abstract][Full Text] [Related]
8. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
[TBL] [Abstract][Full Text] [Related]
9. Validation of the rapid assessment procedure for loiasis (RAPLOA) in the Democratic Republic of Congo.
Wanji S; Akotshi DO; Mutro MN; Tepage F; Ukety TO; Diggle PJ; Remme JH
Parasit Vectors; 2012 Feb; 5():25. PubMed ID: 22300872
[TBL] [Abstract][Full Text] [Related]
10. Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.
Otubanjo OA; Adeoye GO; Ibidapo CA; Akinsanya B; Okeke P; Atalabi T; Adejai ET; Braide E
Rev Biol Trop; 2008 Dec; 56(4):1635-43. PubMed ID: 19419072
[TBL] [Abstract][Full Text] [Related]
11. Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.
Wanji S; Tendongfor N; Esum M; Yundze SS; Taylor MJ; Enyong P
Filaria J; 2005 Apr; 4(1):2. PubMed ID: 15817124
[TBL] [Abstract][Full Text] [Related]
12. Short- and long-term action of multiple doses of ivermectin on loiasis microfilaremia.
Kombila M; Duong TH; Ferrer A; Perret JL; Marion MC; Nguiri C; Gaxotte P; Manfoumbi M; Richard-Lenoble D
Am J Trop Med Hyg; 1998 Apr; 58(4):458-60. PubMed ID: 9574792
[TBL] [Abstract][Full Text] [Related]
13. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
[TBL] [Abstract][Full Text] [Related]
14. Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia.
Fobi G; Gardon J; Santiago M; Ngangue D; Gardon-Wendel N; Boussinesq M
Ophthalmic Epidemiol; 2000 Mar; 7(1):27-39. PubMed ID: 10652169
[TBL] [Abstract][Full Text] [Related]
15. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
[TBL] [Abstract][Full Text] [Related]
16. Loa loa and Mansonella perstans infections in Ijebu north, western Nigeria: a parasitological study.
Agbolade M; Akinboye DO
Jpn J Infect Dis; 2001 Jun; 54(3):108-10. PubMed ID: 11544400
[TBL] [Abstract][Full Text] [Related]
17. Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): Assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment.
Wanji S; Eyong EJ; Tendongfor N; Ngwa CJ; Esuka EN; Kengne-Ouafo AJ; Datchoua-Poutcheu FR; Enyong P; Agnew D; Eversole RR; Hopkins A; Mackenzie CD
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005576. PubMed ID: 28686693
[TBL] [Abstract][Full Text] [Related]
18. The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA).
Zouré HG; Wanji S; Noma M; Amazigo UV; Diggle PJ; Tekle AH; Remme JH
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1210. PubMed ID: 21738809
[TBL] [Abstract][Full Text] [Related]
19. Absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events.
Fokom-Domgue J; Pion SD; Gounoue R; Akame J; Nguipdop-Djomo P; Twum-Danso NA; Thylefors B; Boussinesq M; Kamgno J
Am J Trop Med Hyg; 2014 Feb; 90(2):335-8. PubMed ID: 24420781
[TBL] [Abstract][Full Text] [Related]
20. Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.
Herrick JA; Legrand F; Gounoue R; Nchinda G; Montavon C; Bopda J; Tchana SM; Ondigui BE; Nguluwe K; Fay MP; Makiya M; Metenou S; Nutman TB; Kamgno J; Klion AD
Clin Infect Dis; 2017 Apr; 64(8):1017-1025. PubMed ID: 28329346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
